Follicular Non-Hodgkin's Lymphoma Refractory (DBCOND0110844)

Identifiers

Synonyms

Refractory follicular Non-Hodgkin's lymphoma / Refractory follicular non-hodgkin lymphoma

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Bendamustine	An antineoplastic nitrogen mustard agent used in the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed following rituximab therapy.	Cytochrome P450 1A2enzyme
Ibritumomab tiuxetan	A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.	B-lymphocyte antigen CD20target

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03568929	Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma	Idelalisib	Not Available	Not Available	completed